PATENT CLAIM ANALYSIS

Application Number: 16247132
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-08
Patent Classification: ["546", "113000"]

Abstract:
The present invention relates to compounds of the formula (I), or pharmaceutically acceptable salts, enantiomer or diastereomer thereof, wherein R 1  to R 5  are as described above. The compounds may be useful for the treatment or prophylaxis of hepatitis B virus infection.

Claim (Index 2):
A compound of formula (I) according to  claim 1 , wherein:\n R 1  is C 3-7 cycloalkyl; dioxothiadiazolidinyl, said dioxothiadiazolidinyl being unsubstituted or substituted by benzyl; dioxothiazolidinyl; oxomorpholinyl; oxooxazolidinyl, said oxooxazolidinyl being twice substituted by C 1-6 alkyl; oxopyrrolidinyl, said oxooxazolidinyl being unsubstituted or substituted by cyano or C 1-6  alkyloxadiazolyl; phenyl, said phenyl being twice substituted by halogen; or pyridinyl substituted by halogen; R 2  is H; R 3  is phenyl, said phenyl being once, twice or three times substituted by substituents independently selected from cyano, halogen, C 1-6 alkyl and haloC 1-6 alkyl; pyridinyl, said pyridinyl being once or twice substituted by halogen; or thienyl; R 4  is H; R 5  is H; or a pharmaceutically acceptable salt, enantiomer or diastereomer thereof.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 99.0
- Lexical Diversity: 1.28205
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14997346', '16247170', '16196324', '16247084', '14632078']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8052721758954516
- 35 USC 102 Novelty (BERT): 0.576816527568271
- Combined Prediction Score: 0.7824266110627336
- Mean Citation Score: 415.54647000000006
- Max Citation Score: 473.76462
- Similarity Product: 400.90752318377486

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test